Navigation Links
Knee Pain and Stem Cells: What does the future look like?
Date:3/17/2017

LOS ANGELES, March 17, 2017 /PRNewswire-USNewswire/ -- Medicine is constantly changing. The same is true for stem cell science and Regenerative Medicine in general. The knee has arguably been given the most attention in musculoskeletal and sports medicine as it relates to stem cell treatments.

Dr. Dennis Lox an expert in Regenerative Medicine and stem cell therapy comments that some of the current concepts considered new treatments are actually rooted in older techniques or has been around for a long time.

Continue Reading
Dr. Lox
Dr. Lox

Stem cell transplantation has been refined since bone marrow transplants in the 1960's for leukemia. No longer does a patient need a donor and immunosuppressive drugs with serious side effects. The patient's own stem cells may be used, a technique referred to as autologous therapy.

Decades ago cartilage cells from a patient's own knee were harvested and grown in a lab to greater numbers. Inherent flaws with this technique known as autologous Chondrocyte implantation, led to cartilage overgrowth in some cases, and an aging effect of the lab grown cells rendering their use limited to basically patients under 50.

Similar aging effects can occur with lab grown autologous stem cells. Now the FDA restricts this process considering it a non-approved drug therapy. Utilizing the patient's own knee stem cells the same day without laboratory modification is not considered a drug and is allowed currently in the United States. Dr. Lox who practices in the Tampa Bay, Florida area and Beverly Hills, California states that different rules in different countries may dictate what type of stem cell procedure a patient has. Dr. Lox has treated numerous patients from Canada and the United Kingdom where their health care system is different and using the patient's own stem cells to treat their own knees or another joint is not allowed.

A decade ago many athletes were turning towards Platelet Rich Plasma (PRP) for sports injuries. Famous athletes such as Tiger Woods, Alex Rodriquez and Kobe Bryant were in the news for using PRP. Now famous athletes are in the news for using stem cells for reported improved healing time and repair of injured tissue.

Dr. Lox has stated even more serious career ending injuries such as Avascular Necrosis may be treated with stem cells, not just meniscus tears, or degenerative arthritis. Many patients with knee arthritis wish to avoid a total knee replacement, and Dr. Lox reports that a frequent request for stem cells is to avoid knee replacement surgery.

Now, Regenerative technology has incorporated research that has been used in various other fields for treatment of the knee. Scaffolds seeded with stem cells from a variety of sources are being used and studied. Cells from Perinatal origins (Cord blood, umbilical tissue, amniotic fluid) are being used. 3-D bio-printing is also being studied to make new cartilage for grafting. The future is bright for improvement in the field of Regenerative Medicine in sports and musculoskeletal disorders. Not only is finding ways to help heal our bodies, and improve athletic performance as we age important to  many individuals with knee and other joint complaints, the emergence of preventive and Regenerative Medicine will find an audience as more people understand the role of trauma and the development of degenerative osteoarthritis.

Contact Dr. Lox at www.drlox.com or Call Toll Free 844-440-8503

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/knee-pain-and-stem-cells-what-does-the-future-look-like-300425549.html


'/>"/>
SOURCE Dr. Lox
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry
2. The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities
3. Growing Industry in Technologies For Circulating Tumor Cells: Kalorama Report
4. BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004)
5. BiondVax Publishes Regulatory Approval Strategy for Novel Universal Flu Vaccines in Future Virology Journal
6. Future Is Now: Artificial Intelligence Virtual Consultant Helps Deliver Better Patient Care
7. Accessible Bio Companies Back Up the Importance of “Criminal” DIY Kits for the Future of Science Education
8. Global Cell Banking Market Trends, Opportunities, and Future
9. 2017 World Health Medical Predictions for the Future at CES Las Vegas by Dr. Robert Goldman
10. Resverlogix Announces Successful Phase 1 Renal Trial Results: Clears Path for Future Phase 2 Studies
11. Biocompare, Inc. Launches the Establishing and Maintaining a Cell Culture Facility Future Lab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... , ... April 24, 2017 , ... ... thermal denaturation in a cellular milieu; however, the broad application of this cellular ... simple platforms with sensitive quantitative readouts. Cell-based thermal stabilization assays are valuable methods ...
(Date:4/21/2017)... ... April 21, 2017 , ... The University of Connecticut, ... funding to three startups through the UConn Innovation Fund. The $1.5 million UConn ... affiliated with UConn. , The UConn Innovation Fund provides investments of up to ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... nourishing a range of emerging technology-based businesses, recently earned a $77,518 grant from ... , Founded in 2004, FITCI is Frederick’s first incubator. A non-profit corporation, ...
(Date:4/20/2017)... ... April 20, 2017 , ... USDM Life Sciences , ... sciences and healthcare industries, is pleased to announce Holger Braemer as Vice ... “USDM Europe GmbH” based in Germany. , Braemer is an integral part of ...
Breaking Biology Technology:
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
(Date:4/5/2017)... , April 5, 2017 Today ... announcing that the server component of the HYPR platform ... for providing the end-to-end security architecture that empowers biometric ... HYPR has already secured over 15 million users ... including manufacturers of connected home product suites and physical ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
Breaking Biology News(10 mins):